Literature DB >> 14716144

[New chemotherapeutic options in advanced gastric cancer].

T Höhler1, M Möhler.   

Abstract

Over the last years the therapeutic possibilities for advanced gastric cancer have significantly increased. Here we discuss the new chemotherapeutic options and the existing results in palliative therapy. Copyright 2003 S. Karger GmbH, Freiburg

Entities:  

Mesh：

Year:  2003        PMID： 14716144     DOI： 10.1159/000076176

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


  4 in total

Review 1.  [Palliative treatment options for esophageal and gastric cancer].

Authors:  A Eickhoff; R Jakobs; J F Riemann
Journal:  Internist (Berl)       Date:  2004-07       Impact factor: 0.743

2.  Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication.

Authors:  Yanlei Ma; Huanlong Qin; Qi Zheng; Yu Wang; Zhiguo Wang; Zhe Yang
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

Review 3.  Multidisciplinary management of gastric and gastroesophageal cancers.

Authors:  Markus Moehler; Orestis Lyros; Ines Gockel; Peter-R Galle; Hauke Lang
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

4.  In vitro adenosine triphosphate based chemotherapy response assay in gastric cancer.

Authors:  Seulkee Park; Yanghee Woo; Hogeun Kim; Yong Chan Lee; Sungho Choi; Woo Jin Hyung; Sung Hoon Noh
Journal:  J Gastric Cancer       Date:  2010-12-31       Impact factor: 3.720
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.